A tertiary care experience with paclitaxel and cetuximab as palliative chemotherapy in platinum sensitive and nonsensitive in head and neck cancers

BACKGROUND: The combination of paclitaxel and cetuximab (PaCe) has led to an encouraging response rate in Phase 2 setting with limited toxicity. The aim of our study was to assess the efficacy of this regimen in our setting in platinum sensitive and nonsensitive patients. METHODS: This was a retrosp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:South Asian J Cancer
Main Authors: Noronha, Vanita, Patil, Vijay M., Joshi, Amit, Bhattacharjee, Atanu, Paul, Davinder, Dhumal, Sachin, Juvekar, Shashikant, Arya, Supreeta, Prabhash, Kumar
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2017
Assuntos:
ORIGINAL ARTICLE: Head and Neck Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5379885/
https://ncbi.nlm.nih.gov/pubmed/28413788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2278-330X.202558
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados